187 related articles for article (PubMed ID: 22975871)
21. Immunological function of Langerhans cells in HIV infection.
Matsuzawa T; Ogawa Y; Moriishi K; Shimada S; Kawamura T
J Dermatol Sci; 2017 Aug; 87(2):159-167. PubMed ID: 28433429
[TBL] [Abstract][Full Text] [Related]
22. Significant virus replication in Langerhans cells following application of HIV to abraded skin: relevance to occupational transmission of HIV.
Kawamura T; Koyanagi Y; Nakamura Y; Ogawa Y; Yamashita A; Iwamoto T; Ito M; Blauvelt A; Shimada S
J Immunol; 2008 Mar; 180(5):3297-304. PubMed ID: 18292554
[TBL] [Abstract][Full Text] [Related]
23. Essential roles for dendritic cells in the pathogenesis and potential treatment of HIV disease.
Piguet V; Blauvelt A
J Invest Dermatol; 2002 Aug; 119(2):365-9. PubMed ID: 12190858
[TBL] [Abstract][Full Text] [Related]
24. Caveolin-1 mediated uptake via langerin restricts HIV-1 infection in human Langerhans cells.
van den Berg LM; Ribeiro CM; Zijlstra-Willems EM; de Witte L; Fluitsma D; Tigchelaar W; Everts V; Geijtenbeek TB
Retrovirology; 2014 Dec; 11():123. PubMed ID: 25551286
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 replicates and persists in vaginal epithelial dendritic cells.
Pena-Cruz V; Agosto LM; Akiyama H; Olson A; Moreau Y; Larrieux JR; Henderson A; Gummuluru S; Sagar M
J Clin Invest; 2018 Aug; 128(8):3439-3444. PubMed ID: 29723162
[TBL] [Abstract][Full Text] [Related]
26. Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction.
Hertoghs N; Nijmeijer BM; van Teijlingen NH; Fenton-May AE; Kaptein TM; van Hamme JL; Kappes JC; Kootstra NA; Hahn BH; Borrow P; Ribeiro CMS; Geijtenbeek TBH
PLoS One; 2019; 14(12):e0226651. PubMed ID: 31856198
[TBL] [Abstract][Full Text] [Related]
27. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
[TBL] [Abstract][Full Text] [Related]
28. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross-presentation.
van der Vlist M; de Witte L; de Vries RD; Litjens M; de Jong MA; Fluitsma D; de Swart RL; Geijtenbeek TB
Eur J Immunol; 2011 Sep; 41(9):2619-31. PubMed ID: 21739428
[TBL] [Abstract][Full Text] [Related]
29. Vaginal epidermal dendritic cells: defense against HIV-1 or a safe haven?
Caucheteux S; Piguet V
J Clin Invest; 2018 Aug; 128(8):3228-3230. PubMed ID: 29985165
[TBL] [Abstract][Full Text] [Related]
30. Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission.
Van Herrewege Y; Penne L; Vereecken C; Fransen K; van der Groen G; Kestens L; Balzarini J; Vanham G
AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1091-102. PubMed ID: 12396448
[TBL] [Abstract][Full Text] [Related]
31. Maturation of blood-derived dendritic cells enhances human immunodeficiency virus type 1 capture and transmission.
Izquierdo-Useros N; Blanco J; Erkizia I; Fernández-Figueras MT; Borràs FE; Naranjo-Gómez M; Bofill M; Ruiz L; Clotet B; Martinez-Picado J
J Virol; 2007 Jul; 81(14):7559-70. PubMed ID: 17475656
[TBL] [Abstract][Full Text] [Related]
32. Calcitonin Gene-Related Peptide Induces HIV-1 Proteasomal Degradation in Mucosal Langerhans Cells.
Bomsel M; Ganor Y
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904199
[TBL] [Abstract][Full Text] [Related]
33. "HIV-peplotion vaccine"--a novel approach to protection against AIDS by transepithelial transport of viral peptides to Langerhans cells for long-term antiviral CTL response. (A review).
Becker Y
Acta Microbiol Immunol Hung; 1996; 43(1):1-17. PubMed ID: 8806938
[TBL] [Abstract][Full Text] [Related]
34. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.
Arrighi JF; Pion M; Wiznerowicz M; Geijtenbeek TB; Garcia E; Abraham S; Leuba F; Dutoit V; Ducrey-Rundquist O; van Kooyk Y; Trono D; Piguet V
J Virol; 2004 Oct; 78(20):10848-55. PubMed ID: 15452205
[TBL] [Abstract][Full Text] [Related]
35. Innate signaling in HIV-1 infection of dendritic cells.
van der Vlist M; van der Aar AM; Gringhuis SI; Geijtenbeek TB
Curr Opin HIV AIDS; 2011 Sep; 6(5):348-52. PubMed ID: 21743322
[TBL] [Abstract][Full Text] [Related]
36. Monocytes, dendritic cells, and Langerhans cells in human immunodeficiency virus infection.
Kalter DC; Gendelman HE; Meltzer MS
Dermatol Clin; 1991 Jul; 9(3):415-28. PubMed ID: 1873923
[TBL] [Abstract][Full Text] [Related]
37. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
[TBL] [Abstract][Full Text] [Related]
38. Dendritic-cell interactions with HIV: infection and viral dissemination.
Wu L; KewalRamani VN
Nat Rev Immunol; 2006 Nov; 6(11):859-68. PubMed ID: 17063186
[TBL] [Abstract][Full Text] [Related]
39. Calcitonin gene-related peptide inhibits human immunodeficiency type 1 transmission by Langerhans cells via an autocrine/paracrine feedback mechanism.
Ganor Y; Drillet-Dangeard AS; Bomsel M
Acta Physiol (Oxf); 2015 Feb; 213(2):432-41. PubMed ID: 25142255
[TBL] [Abstract][Full Text] [Related]
40. Dendritic Cells, the Double Agent in the War Against HIV-1.
Martín-Moreno A; Muñoz-Fernández MA
Front Immunol; 2019; 10():2485. PubMed ID: 31708924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
